DSM Pharmaceuticals, Inc. has signed a manufacturing agreement with APT Pharmaceuticals, Inc. DSM will produce the commercial drug supply as a sterile product for pulmonary delivery for APT. The agreement will utilize DSM’s commercial facilities in Greenville, NC. “DSM has a superior reputation in sterile manufacturing, experience with similar drug products, and an excellent working relationship with the FDA,” commented Howard Raff, Ph.D., APT’s chief operating officer...